Pfizer announces FDA acceptance of New Drug Application for Bosutinib
27 January 2012
The U.S. FDA has accepted its NDA for standard review of bosutinib...
News
The latest news from the pharmaceutical industry. If you have a piece of news that you would like us to cover, please contact Pippa McCartney on +44(0) 1959 563311 or email us.
U.S. Food and Drug Administration approves Pfizer’s INLYTA® (axitinib)
27 January 2012
First treatment to demonstrate superior benefit in a Phase 3 study compared with another targeted agent in advanced RCC...
GSK announces changes to the Board
27 January 2012
GlaxoSmithKline plc announced that Sir Crispin Davis, Sir Robert Wilson and Mr Larry Culp will not stand for re-election to the Board...
Boehringer Ingelheim Moves into Phase III for its Head and Neck Cancer Trial Programme for Afatinib*
26 January 2012
Boehringer Ingelheim announced the initiation of two phase III clinical trials...
Syrris custom reactors – built for you
26 January 2012
Syrris Custom Reactor Systems are ideally suited to processes requiring large reactor vessels...
Roche responds to adoption of shareholder rights plan by Illumina Board of Directors
26 January 2012
Roche has responded to an announcement from Illumina, Inc...
ASCEND study to evaluate the effectiveness of TYSABRI® (natalizumab) as a treatment for SPMS
26 January 2012
Biogen Idec and Elan Corporation, plc announced a global Phase 3b study, ASCEND, that is being conducted to evaluate the effectiveness of TYSABRI as a treatment for SPMS...
Amgen to acquire Micromet
26 January 2012
Amgen and Micromet, Inc. announced that the companies have entered into a definitive merger agreement...
Boehringer Ingelheim launches ‘Lean-to-Clinic’ program for fast drug product supply
26 January 2012
Boehringer Ingelheim has expanded its biopharmaceutical cell line development services...
New FDA approved labeling for VYTORIN® (Ezetimibe/Simvastatin)
25 January 2012
The FDA has approved an updated label for VYTORIN® (ezetimibe/simvastatin)...
Roche offers to acquire all outstanding shares of Illumina, Inc. to further strengthen its leading role in diagnostics
25 January 2012
Roche announced that it is proposing to acquire all outstanding shares of Illumina, Inc...
PAT supplement
This free to view PAT supplement is sponsored by Sartorius, Extrel, ABB, Bruker Optics and FOSS NIRSystems:
Company directory
ABB Analytical Measurements | Almac | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Daltonik GmbH | CAMO Software AS | CI Precision | Cisbio Bioassays | Colder Products Company | Expo Technologies, LLC. | Freeman Technology | GE Analytical Instruments | HACH LANGE GMBH | HORIBA Scientific | Hudson Robotics, Inc. | Natoli Engineering Company, Inc. | Peter Huber Kältemaschinenbau GmbH | Randox Pharma Services | Rapid Micro Biosystems | Smithers Viscient | Synbiosis | Syngene | Watson-Marlow Pumps Group |
Login to access exclusive content